Reaching the sustainable development goals through healthy environments: are we on track?


Journal

European journal of public health
ISSN: 1464-360X
Titre abrégé: Eur J Public Health
Pays: England
ID NLM: 9204966

Informations de publication

Date de publication:
01 03 2020
Historique:
entrez: 12 5 2020
pubmed: 12 5 2020
medline: 18 5 2021
Statut: ppublish

Résumé

The adoption of the 2030 Agenda for Sustainable Development in 2015 opened new opportunities to work towards healthy environments through 'whole of government' and 'whole of society' approaches. It created a strong policy platform that acknowledges health as a result and an enabler of sustainable policies across all sectors of government. Five years into the process, an initial analysis of emerging trends indicates that, despite some encouraging developments in policy as well as overall progress in economy and technology, there remains a gap between rhetoric, ambition and reality. In particular, the monitoring system for environment and health-related sustainable development goals (SDGs) and targets requires further development; inequalities in environment and health persist and in some areas have increased; equity is not yet a central element of implementation and reporting on the achievement of the SDGs; and, most worrying of all, trends in key environmental indicators that are vital to the survival of the human species, such as those related to climate change and biodiversity, are still on an overall negative path. In summary, governments must significantly and rapidly increase action to secure the habitability and safety of planet Earth. The public health community assumes an unprecedented role in placing and maintaining health and equity at the heart of the political agenda. This demands new governance models conferring on the health sector a clear mandate and legitimacy to operate across sectors. It also requires enhancing capacities among health professionals to embrace this new level of complexity, understand the multiple links between sectoral policies and health, and successfully engage with other government sectors and stakeholders.

Identifiants

pubmed: 32391904
pii: 5835788
doi: 10.1093/eurpub/ckaa028
pmc: PMC7213421
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

i14-i18

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Informations de copyright

© World Health Organization, 2020. All rights reserved. The World Health Organization has granted the Publisher permission for the reproduction of this article.

Références

Public Health. 2015 Oct;129(10):1383-9
pubmed: 24099716
Science. 2015 Feb 13;347(6223):1259855
pubmed: 25592418
Lancet. 2019 Nov 16;394(10211):1836-1878
pubmed: 31733928
Front Ecol Environ. 2009 Apr;7(3):150-157
pubmed: 32313513

Auteurs

F Racioppi (F)

World Health Organization European Centre for Environment and Health, Bonn, Germany.

M Martuzzi (M)

World Health Organization Asia-Pacific Centre for Environment and Health, Seoul, Republic of Korea.

S Matić (S)

World Health Organization Regional Office for Europe, Copenhagen, Denmark.

M Braubach (M)

World Health Organization European Centre for Environment and Health, Bonn, Germany.

G Morris (G)

WHO Collaborating Centre on Natural Environments and Health, European Centre for Environment and Human Health, University of Exeter Medical School, Exeter, UK.

M Krzyżanowski (M)

Environmental Research Group, School of Population Health and Environmental Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.

D Jarosińska (D)

World Health Organization European Centre for Environment and Health, Bonn, Germany.

O Schmoll (O)

World Health Organization European Centre for Environment and Health, Bonn, Germany.

D Adamonytė (D)

World Health Organization European Centre for Environment and Health, Bonn, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH